Problems with currently available antidepressants
- PMID: 10910012
Problems with currently available antidepressants
Abstract
Although options for pharmacologic treatment for depression have grown seemingly exponentially over the past several decades, the current armamentarium of antidepressants continues to have limitations of both efficacy and tolerability. The problems include an unacceptable lack of efficacy, delayed onset of therapeutic effects, an inability to predict responses to one or another agent, drug-drug interactions, and difficulty with tolerability during both acute and chronic treatment. This article reviews the problems that persist in the use of currently available antidepressant medications and presents a list of attributes that would be characteristic of the ideal antidepressant.
Similar articles
-
Extrapyramidal symptoms associated with antidepressants--a review of the literature and an analysis of spontaneous reports.Ann Clin Psychiatry. 2010 Aug;22(3):148-56. Ann Clin Psychiatry. 2010. PMID: 20680187 Review.
-
Pharmacologic characteristics of ideal antidepressants in the 21st century.J Clin Psychiatry. 2000;61 Suppl 11:4-8. J Clin Psychiatry. 2000. PMID: 10926049 Review.
-
[Individualized treatment with antidepressants].Fortschr Neurol Psychiatr. 2013 Feb;81(2):104-16; quiz 117-8. doi: 10.1055/s-0032-1330403. Epub 2013 Feb 14. Fortschr Neurol Psychiatr. 2013. PMID: 23412962 German. No abstract available.
-
Clinical implications of antidepressant drug effects on sexual function.Ann Clin Psychiatry. 1995 Dec;7(4):189-201. doi: 10.3109/10401239509149625. Ann Clin Psychiatry. 1995. PMID: 8721893 Review.
-
Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:35-9. doi: 10.1097/00004850-199609004-00005. Int Clin Psychopharmacol. 1996. PMID: 8923125 Review.
Cited by
-
Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation.Pharmacol Rep. 2024 Oct;76(5):1001-1011. doi: 10.1007/s43440-024-00630-4. Epub 2024 Jul 23. Pharmacol Rep. 2024. PMID: 39042346 Free PMC article.
-
Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.Adv Exp Med Biol. 2024;1456:359-378. doi: 10.1007/978-981-97-4402-2_18. Adv Exp Med Biol. 2024. PMID: 39261438 Review.
-
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.J Neurosci. 2002 Jan 15;22(2):389-95. doi: 10.1523/JNEUROSCI.22-02-00389.2002. J Neurosci. 2002. PMID: 11784783 Free PMC article.
-
Escitalopram versus citalopram: the surprising role of the R-enantiomer.Psychopharmacology (Berl). 2004 Jul;174(2):163-76. doi: 10.1007/s00213-004-1865-z. Psychopharmacology (Berl). 2004. PMID: 15160261 Review.
-
Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model.Bioorg Med Chem. 2014 Jan 1;22(1):311-24. doi: 10.1016/j.bmc.2013.11.017. Epub 2013 Nov 19. Bioorg Med Chem. 2014. PMID: 24315194 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous